SENATE DEBATES NEW PHARMACY PROMPT-PAYMENTYMENT LEGISLATION

Published Online: Monday, October 1, 2007

Community pharmacists who submit reimbursement claims electronically to Medicare Part D drug plans would receive payment in 14 days or less, under new legislation introduced by Senate Finance Committee Chairman Max Baucus (D, Mont) and the panel's top-ranking Republican, Iowa Sen Charles Grassley.

The bill would further require that reimbursements to electronic- filing pharmacies be made instantly via electronic funds transfer- an approach designed to eliminate "the check's in the mail" excuses from Medicare drug plans. Pharmacies that file paper claims for Part D drugs would have to be reimbursed within 30 days.

Noting that pharmacists are "struggling" due to slow payments for Part D drugs, Baucus told Congress, "We must act now, before pharmacists find that they are no longer able to provide drugs to Medicare beneficiaries, or to provide drugs at all."

In addition to requiring prompt payment for claims, the legislation would prohibit drug chains from placing their logos on Part D membership cards-a practice Sen Baucus called "confusing" to Medicare patients. The bill also would require plans to allow "safety net pharmacies" that serve "vulnerable patients" to join their networks.

Still another provision would require plans to provide pharmacists with more accurate and updated information about reimbursement rates before a drug is dispensed. "The problems that pharmacists are facing...are real," and "they are not going away," said Baucus.



Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$
VSEO N/A